Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials

Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials

Cholangiocarcinoma (CCA) is a highly-aggressive malignancy arising from the biliary tree, characterized by a steady increase in incidence globally and a high mortality rate. Most CCAs are diagnosed in the advanced and metastatic phases of the disease, due to the paucity of signs and symptoms in the...

Full description

Bibliographic Details
Main Authors: Maria Maddalena Simile, Paola Bagella, Gianpaolo Vidili, Angela Spanu, Roberto Manetti, Maria Antonietta Seddaiu, Sergio Babudieri, Giordano Madeddu, Pier Andrea Serra, Matteo Altana, Panagiotis Paliogiannis
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Medicina
Subjects:
cancer
biliary tree
cholangiocarcinoma
molecular pathways
genomics
targeted therapies
Online Access:https://www.mdpi.com/1010-660X/55/2/42

Internet

https://www.mdpi.com/1010-660X/55/2/42

Similar Items